4//SEC Filing
Brake Rachael Louise 4
Accession 0001209191-22-006511
CIK 0001595097other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:49 PM ET
Size
5.5 KB
Accession
0001209191-22-006511
Insider Transaction Report
Form 4
Brake Rachael Louise
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+570,800→ 570,800 totalExercise: $0.47Exp: 2032-02-01→ Common Stock (570,800 underlying)
Footnotes (1)
- [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001898023
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:49 PM ET
- Size
- 5.5 KB